In-Chul Kim

Corporate Officer/Principal presso KAINOS MEDICINE, INC.

73 anni

Health Technology

Consumer Services

Profilo

In-Chul Kim is currently the President & Chief Executive Officer at National OncoVenture.
He is also the Vice Chairman at Kainos Medicine, Inc., the Director at Institut Pasteur Korea Research Foundation, and the Chief Strategic Officer at Kainos Medicine, Inc. Dr. Kim holds a doctorate degree from the University of Illinois.

Posizioni attive di In-Chul Kim

Società	Posizione	Inizio
KAINOS MEDICINE, INC.	Corporate Officer/Principal	-
Institut Pasteur Korea Research Foundation Institut Pasteur Korea Research Foundation BiotechnologyHealth Technology Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea.	Director/Board Member	-
National OncoVenture	Chief Executive Officer	-

Tutte le posizioni attive di In-Chul Kim

Formazione di In-Chul Kim

University of Illinois

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di In-Chul Kim

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
KAINOS MEDICINE, INC.	Health Technology

Aziende private	2
Institut Pasteur Korea Research Foundation Institut Pasteur Korea Research Foundation BiotechnologyHealth Technology Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea.	Health Technology
National OncoVenture